CLINICAL AND LABORATORY ASPECTS OF NEUROVASCULAR PATHOLOGY IN ADOLESCENTS
DOI:
https://doi.org/10.31149/ijnps.v4i4.2882Keywords:
Cerebrovascular Pathology, Adolescents, Laboratory Diagnostics, Biomarkers, Endothelial Dysfunction, Cerebral Circulatory Disorders, Pubertal PeriodAbstract
Cerebrovascular pathology in adolescence represents a pressing medical and social problem that requires special attention due to the age-related characteristics of brain vascular system formation. The pubertal period is characterized by intensive neuroendocrine restructuring, changes in hemodynamics, and metabolic processes, which creates prerequisites for the development of various forms of cerebral circulatory disorders.
References
[1] E. F. Ibragimova and L. M. Garifulina, “Markers of endothelial dysfunction in children with obesity,” Medical Science of Uzbekistan, no. 3, pp. 107–111, 2025.
[2] Zh. D. Kobalava, S. V. Nedogoda, E. V. Shlyakhto et al., “Hypertension in adults: Clinical recommendations,” Russian Cardiological Journal, vol. 29, Art. no. 6117, 2024.
[3] N. S. Luksha, O. N. Grishkevich, N. A. Gubich et al., “The state of the endothelium in hyperhomocysteinemia in children with arterial hypertension,” Journal of the Grodno State Medical University, vol. 21, no. 4, pp. 462–468, 2023.
[4] Z. U. Todieva, N. E. Zvartau, and S. Yu. Nikitina et al., “Endothelial dysfunction in obese adolescents: clinical and laboratory markers and link with cardiometabolic risk,” Pediatrics. Medicum medicum, no. 1, pp. 46–52, 2022.
[5] Yu. A. Khachaturov, I. O. Shchederkina, and N. F. Plavunov et al., “Stroke in children and adolescents,” Journal of Neurology and Psychiatry named after S.S. Korsakov, vol. 122, no. 12, pp. 76–83, 2022.
[6] P. Ambrosino, R. Lupoli, A. Di Minno et al., “Endothelial dysfunction and arterial hypertension in children: pathophysiology and clinical implications,” Journal of Cardiovascular Development and Disease, vol. 9, no. 5, p. 136, 2022.
[7] A. Engin, “Endothelial dysfunction in hypertension,” in Advances in Experimental Medicine and Biology, vol. 1460, pp. 489–538, 2024.
[8] T. Hertis Petek, D. Enko, L. Pertl et al., “Arterial hypertension and oxidative stress/inflammation markers in children and adolescents,” Antioxidants (Basel), vol. 11, no. 5, p. 1026, 2022.
[9] E. F. Ibragimova and L. M. Garifullina, “Role of endothelial dysfunction in the development of cardiovascular complications in children with abdominal obesity,” International Journal of Scientific Pediatrics, vol. 3, no. 8, pp. 710–718, 2024.
[10] M. M. Islam, M. Z. Hossain, M. M. Rahman et al., “Prevalence, trends, and determinants of hypertension among adolescents: a systematic review and meta-analysis,” Journal of Global Health, vol. 15, Art. no. 04115, 2025.
[11] Yu. A. Khachaturov, I. O. Shchederkina, and N. F. Plavunov et al., “Stroke in children and adolescents,” Neuroscience and Behavioral Physiology, vol. 53, no. 6, pp. 994–1001, 2023.
[12] M. Angelo Mastr, C. Azzari, C. D’Aleo et al., “Pediatric arterial ischemic stroke: risk factors and diagnostic challenges,” European Journal of Pediatrics, vol. 180, no. 4, pp. 1107–1115, 2021.
[13] V. Micieta, A. Jurko, and I. Brucknerová, “Endothelial dysfunction in adolescent hypertension: diagnostic challenges and early cardiovascular risk,” Journal of Cardiovascular Development and Disease, vol. 12, no. 9, p. 326, 2025.
[14] P. B. Sporns, R. Sträter, J. Minnerup et al., “Treatment in pediatric stroke and outcomes: results from the German ‘Save ChildS’ study,” Stroke, vol. 52, no. 2, pp. 200–208, 2021.
[15] M. Wójcik and A. Kotara-Kozakowska, “Obesity, sodium homeostasis, and arterial hypertension in children and adolescents,” Nutrients, vol. 13, no. 11, p. 4032, 2021.
